Apoptosis and fibrosis are early features of heart failure in an animal model of metabolic cardiomyopathy.
In previous experiments, we observed signs of cardiac failure in mice overexpressing lipoprotein lipase (LPL) under the control of a muscle specific promotor and in peroxisome proliferators activated receptor alpha (PPARalpha) knockout mice overexpressing LPL under the control of the same promotor. In our current investigations, we focussed on morphological consequences and changes in mRNA and protein expression in hearts from these animals. mRNA expression was analysed by differential display analysis and Northern blot as well as by cDNA microarray analysis followed by pathway analysis. Protein expression was examined using immunoblot and immunohistochemistry. Fibrosis was determined by chromotrope aniline blue staining for collagen. A distinct increase in the expression of alpha-tubulin mRNA was noted in hearts of all mutant mouse strains compared with the control. This result was paralleled by increased alpha-tubulin protein expression. Using cDNA microarray analysis, we detected an activation of apoptosis, in particular an increase of caspase-3 expression in hearts of mice overexpressing LPL but not in PPARalpha knockout mice overexpressing LPL. This finding was confirmed immunohistochemically. In addition, we identified a distinct interstitial increase in collagen and an increase around blood vessels. In our mouse model, we detect mRNA and protein changes typical for cardiomyopathy even before overt clinical signs of heart failure. In addition, a small but distinct increase in the rate of apoptosis of cardiomyocytes and fibrotic changes contributes to cardiac failure in mice overexpressing LPL, whereas additional deficiency in PPARalpha seems to protect hearts from these effects.
Gürtl
Barbara
B
Department of Molecular Biology and Biochemistry, Medical University of Graz, Graz, Austria.
Kratky
Dagmar
D
Guelly
Christian
C
Zhang
Lefeng
L
Gorkiewicz
Gregor
G
Das
Suman Kumar
SK
Tamilarasan
Kuppusamy Palaniappan
KP
Hoefler
Gerald
G
D000818:Animals; D017209:Apoptosis; D015152:Blotting, Northern / Q000379:methods; D009202:Cardiomyopathies / Q000150:complications* / Q000378:metabolism / Q000473:pathology; D004195:Disease Models, Animal; D005355:Fibrosis; D015870:Gene Expression; D006333:Heart Failure / Q000209:etiology* / Q000378:metabolism / Q000473:pathology; D008071:Lipoprotein Lipase / Q000378:metabolism; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D008822:Mice, Transgenic; D009206:Myocardium / Q000473:pathology; D020411:Oligonucleotide Array Sequence Analysis / Q000379:methods; D047493:PPAR alpha / Q000172:deficiency; D012333:RNA, Messenger / Q000235:genetics; D014404:Tubulin / Q000235:genetics / Q000378:metabolism
D047493:PPAR alpha; D012333:RNA, Messenger; D014404:Tubulin; D008071:Lipoprotein Lipase